No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
137 |
4. Check minimum number of eventsNone |
137 |
5. Include endpointsNone |
137 |
6. Filter based on genotype QC (FinnGen only) |
133 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of meninges, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 133 | 81 | 52 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 61.12 | 57.84 | 66.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 137
- Matched controls
- 1370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
+∞
88.3
75
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
30.6
79.7
61
35
H02AB02
ATC
dexamethasone; systemic
202.9
67.0
65
6
XX3DW
NOMESCO Finland
Time consuming IT work
21.2
49.9
42
28
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
132.3
43.9
45
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
17.7
38.9
35
26
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
103.9
36.0
38
5
130
Kela drug reimbursment
Malignant tumour
+∞
33.7
31
*
C70.9
ICD-10 Finland
Malignant neoplasm: Meninges, unspecified
+∞
31.5
29
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
182.2
28.9
29
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.2
25.6
49
98
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.7
23
*
ZXE20
NOMESCO Finland
More than three and less than five hours
7.3
24.7
46
89
N03AX14
ATC
levetiracetam; systemic
79.4
23.8
26
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
22.5
21
*
JN4BD
NOMESCO Finland
Extensive body CT
9.4
20.3
27
35
A04AA02
ATC
granisetron; systemic, transdermal
218.7
19.0
19
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
61.4
18.5
21
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
17.0
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
192.5
16.9
17
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
35.0
16.7
21
7
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
38.6
16.2
20
6
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
15.9
15
*
WF002
NOMESCO Finland
Radical radiotherapy
179.7
15.8
16
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
15.7
21
9
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
22.3
14.8
21
11
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
167.1
14.8
15
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
25.7
14.7
20
9
WZC00
NOMESCO Finland
Treatment plan or consultation
4.1
14.6
62
230
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.8
13.3
19
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.7
12
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
142.5
12.7
13
*
ZXC95
NOMESCO Finland
Use of surgical navigator
33.4
11.9
15
5
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
33.4
11.9
15
5
C70.1
ICD-10 Finland
Malignant neoplasm: Spinal meninges
+∞
11.6
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.6
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.6
11
*
A04AA01
ATC
ondansetron; systemic, rectal
14.7
10.5
17
13
ZXE30
NOMESCO Finland
More than five and less than seven hours
12.8
10.4
18
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
10.2
37
120
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
10.1
66
309
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
22.0
10.0
14
7
AA1BD
NOMESCO Finland
Extensive CT of head and brain
16.6
9.8
15
10
Z51.5
ICD-10 Finland
Palliative care
11.9
9.6
17
16
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.5
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.5
9
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
9.5
9
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
9.5
9
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
9.5
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
L01AX03
ATC
temozolomide; systemic
+∞
9.5
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
9.1
45
177
AA1AD
NOMESCO Finland
CT of head and brain
3.0
9.0
59
273
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.5
8.5
16
17
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
95.7
8.5
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
8.4
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.8
8.3
14
12
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
35.7
8.2
10
*
N02AA05
ATC
oxycodone; systemic
3.6
8.2
32
108
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
23.7
8.2
11
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
8.0
26
77
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.5
7.5
12
9
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
84.5
7.5
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
84.5
7.5
8
*
L03AA13
ATC
pegfilgrastim; parenteral
84.5
7.5
8
*
L02BA01
ATC
tamoxifen; oral
84.5
7.5
8
*
WX402
NOMESCO Finland
General anaesthesia
3.3
7.5
33
120
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
7.4
7
*
L03AA02
ATC
filgrastim; parenteral
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.4
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.4
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.4
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
7.4
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
7.2
23
67
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.0
7.2
17
27
N03AF02
ATC
oxcarbazepine; oral
10.1
7.0
13
14
XX2RW, ,
NOMESCO Finland
42.2
6.8
8
*
JN4AD
NOMESCO Finland
Body CT examination
6.3
6.7
17
30
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
73.1
6.5
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
73.1
6.5
7
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
28.1
6.3
8
*
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
6.3
6
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
1921A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Cerebral meninges
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
45
6.90
15.10
4.6
5.9
24.56
25.49
mmol/l
0.51
26
45
36
100
4.53
12.33
5.6
3.0
—
—
—
0
0
30
112
3.15
6.44
5.0
5.4
1.69
1.95
mmol/l
0.21
25
94
56
298
2.49
6.08
3.3
2.8
0.31
0.46
e6/l
0.44
46
215
14
24
6.37
5.70
3.6
1.4
—
—
—
0
0
80
510
2.37
5.69
9.8
4.9
1.21
1.22
mmol/l
0.25
62
446
30
121
2.89
5.60
3.9
4.6
105.40
103.89
mmol/l
1.36
30
121
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
26
5.87
5.39
2.2
2.1
0.40
0.46
u/ml
—
7
12
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
17
53
3.52
4.80
5.2
7.1
94.91
92.66
%
1.17
17
53
11
19
6.19
4.54
2.5
2.1
4.85
4.95
kpa
0.14
11
19
69
445
2.11
4.41
7.0
3.2
34.27
35.74
g/l
1.60
64
415
60
369
2.11
4.33
3.4
3.0
—
—
—
0
0
68
443
2.06
4.17
3.5
2.1
—
—
—
0
0
39
207
2.24
4.04
6.9
2.1
2.49
2.44
mmol/l
0.68
34
169
16
54
3.22
4.00
5.1
6.9
0.66
0.78
%
0.58
16
54
9
17
5.58
3.57
5.1
3.5
53.00
58.88
%
—
9
17
6
6
10.38
3.53
1.0
1.3
—
—
—
0
0
9
18
5.27
3.43
1.9
1.2
—
—
—
0
0
38
215
2.06
3.29
3.6
1.9
—
—
—
0
0
70
505
1.79
2.83
17.2
14.3
1.36
1.35
inr
0.04
34
145
9
23
4.11
2.83
1.3
1.4
—
—
—
0
0
42
259
1.90
2.81
4.6
4.3
0.00
0.00
estimate
-0.00
29
70
51
345
1.76
2.50
2.0
2.0
126.67
217.06
u/l
0.65
51
327
6
13
4.77
2.29
2.0
1.2
—
—
—
0
0
12
51
2.48
2.01
8.9
1.6
5.66
2.67
ug/l
0.54
12
36
61
456
1.61
1.97
3.4
3.8
16.58
34.74
ng/l
2.99
50
328
7
169
0.38
1.95
1.6
1.5
—
—
—
0
0
6
17
3.64
1.86
2.0
1.2
—
—
—
0
0
8
30
2.77
1.75
1.1
1.2
—
—
—
0
0
14
70
2.11
1.66
1.9
1.6
—
—
—
0
0
6
20
3.09
1.60
2.0
1.2
—
—
—
0
0
96
1079
0.63
1.59
4.4
4.6
6.00
5.97
mmol/l
0.04
82
973
7
27
2.68
1.53
1.7
1.9
93.14
94.22
%
—
7
27
53
407
1.49
1.42
4.5
3.8
—
—
—
0
0
90
1018
0.66
1.42
6.1
6.2
41.28
40.38
mmol/mol
0.47
81
944
6
24
2.57
1.32
13.0
2.0
7.83
13.32
u/ml
—
6
19
5
18
2.84
1.29
1.2
2.3
—
109.80
—
0
5
8
35
2.36
1.29
1.5
3.1
—
—
—
0
0
28
191
1.59
1.27
2.9
2.5
1.28
1.21
e6/l
0.03
14
100
65
533
1.42
1.20
4.2
3.7
0.00
0.00
estimate
-0.00
29
69
64
525
1.41
1.17
5.9
5.0
0.00
0.00
estimate
-0.00
27
71
63
518
1.40
1.13
4.3
3.7
0.00
0.00
estimate
-0.00
29
83
27
368
0.67
1.06
3.4
3.6
17.58
8.71
mg/mmol
0.22
16
213
100
1090
0.69
1.04
4.1
5.2
2.73
2.68
mmol/l
0.21
87
1000
55
448
1.38
1.02
2.6
2.4
80.28
77.76
nmol/l
0.28
46
390
31
229
1.46
0.98
2.0
1.7
1.15
1.04
mg/l
0.17
24
176
11
63
1.81
0.93
1.5
1.5
—
—
—
0
0
31
234
1.42
0.88
1.8
1.8
449.43
31250440.21
pmol/l
0.50
23
192
25
181
1.47
0.88
3.4
2.8
4.52
2.56
e6/l
0.22
12
92
5
24
2.12
0.75
1.8
1.3
—
—
—
0
0
5
24
2.12
0.75
1.8
1.3
—
—
—
0
0
20
147
1.42
0.66
3.4
2.4
12.67
12.62
umol/l
0.01
20
138
18
131
1.43
0.63
7.5
4.0
0.91
1.02
mmol/l
0.78
18
117
5
30
1.69
0.62
2.2
1.5
0.17
0.22
g/l
—
5
30
99
1054
0.78
0.58
3.6
4.6
1.50
1.51
mmol/l
0.02
85
964
112
1060
1.31
0.54
27.8
12.6
21.16
23.30
mg/l
0.44
103
813
9
62
1.48
0.54
1.4
1.6
—
—
—
0
0
6
100
0.58
0.54
1.7
1.7
27.83
28.92
u/l
—
6
80
95
1010
0.81
0.50
3.4
4.2
1.27
1.29
mmol/l
0.13
84
916
21
165
1.32
0.48
2.1
1.6
—
—
—
0
0
89
826
1.22
0.48
4.7
4.0
14.87
14.91
pmol/l
0.06
81
747
14
184
0.73
0.45
1.2
1.3
12.51
7.60
u/ml
—
7
60
26
313
0.79
0.45
1.7
1.7
1.36
1.37
mmol/l
0.02
18
268
5
31
1.64
0.43
2.0
1.5
1.07
1.09
g/l
—
5
31
52
579
0.84
0.42
3.1
3.0
—
—
—
0
0
5
33
1.53
0.42
1.6
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
6
41
1.48
0.36
1.5
1.7
—
—
—
0
0
105
1004
1.20
0.34
26.1
11.6
78.57
76.87
ml/min/173m2
0.35
98
815
19
228
0.81
0.32
4.4
3.7
26.42
23.77
%
—
10
103
102
1062
0.85
0.32
3.7
4.6
4.68
4.62
mmol/l
0.20
90
978
25
216
1.19
0.28
2.1
1.6
1152.25
1125.75
nmol/l
0.05
16
162
16
189
0.83
0.24
1.4
1.3
54.99
27.03
iu/ml
—
7
63
14
116
1.23
0.23
1.7
1.7
—
—
—
0
0
14
117
1.22
0.21
1.8
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
9.07
—
0
8
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
270.94
—
0
14
13
152
0.84
0.18
1.5
1.4
—
—
—
0
0
7
86
0.80
0.15
1.4
1.8
—
—
—
0
0
18
162
1.13
0.12
4.3
2.6
0.80
0.78
ug/l
0.05
13
103
6
55
1.09
0.09
3.0
2.1
0.73
1.10
%
—
6
55
6
58
1.04
0.08
1.0
1.1
—
—
—
0
0
38
365
1.06
0.06
2.7
3.1
634.44
1445.76
ng/l
1.98
33
303
99
1005
0.95
0.06
5.4
4.7
2.16
1.89
mu/l
1.14
90
908
28
294
0.94
0.06
1.4
1.6
18.17
21.81
nmol/l
0.58
23
253
46
472
0.96
0.04
2.0
2.0
86.87
98.13
pmol/l
0.80
21
240
82
810
1.03
0.03
4.8
3.9
14.08
12.01
mm/h
0.44
75
736
117
1174
0.98
0.00
38.3
18.2
39.12
39.81
%
0.63
112
1085
13
135
0.96
0.00
5.5
6.6
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
7.60
—
0
5
7
78
0.89
-0.00
1.4
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.6
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
585.40
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MENINGES_WIDE – Malignant neoplasm of meninges, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).